ARTICLE | Top Story
Actelion, GSK in almorexant deal
July 15, 2008 1:16 AM UTC
Actelion (SWX:ATLN) granted GlaxoSmithKline (LSE:GSK; NYSE:GSK) exclusive worldwide rights to co-develop and co-commercialize almorexant outside of Japan. The orexin 1 receptor ( OX1R) and orexin 2 re...